Lopiano, Leonardo
Modugno, Nicola
Marano, Pietro
Sensi, Mariachiara
Meco, Giuseppe
Solla, Paolo
Gusmaroli, Graziano
Tamma, Filippo
Mancini, Francesca
Quatrale, Rocco
Zangaglia, Roberta
Bentivoglio, Annarita
Eleopra, Roberto
Gualberti, Giuliana
Melzi, Gabriella http://orcid.org/0000-0001-9944-3810
Antonini, Angelo
Funding for this research was provided by:
AbbVie Italy (NA)
Article History
Received: 22 January 2019
Revised: 18 April 2019
Accepted: 23 April 2019
First Online: 27 May 2019
Compliance with ethical standards
:
: Angelo Antonini has received compensation for consultancy and speaker-related activities from UCB, Boehringer Ingelheim, AbbVie, Zambon, Bial, Lundbeck; he receives research support from Chiesi Pharmaceuticals, Lundbeck, Horizon 2020 - PD_Pal Grant 825785, Ministry of Education University and Research (MIUR) Grant ARS01_01081. He serves as consultant for Boehringer–Ingelheim for legal cases on pathological gambling. Graziano Gusmaroli, Pietro Marano, Nicola Modugno, Rocco Quatrale, Mariachiara Sensi, Paolo Solla, and Filippo Tamma have received honoraria for consulting services and symposia from AbbVie. Leonardo Lopiano has received honoraria for consulting services and symposia from AbbVie, Zambon, UCB, DOC, Chiesi, and Bial. Francesca Mancini has received honoraria for consulting services and symposia from AbbVie and Zambon. Roberto Eleopra has received compensation for consultancy and speaker-related activities from Ipsen SpA, Boston Scientific, BrainLab Germany. Rocco Quatrale has received compensation for consultancy and speaker from AbbVie and Zambon. Annarita Bentivoglio received honorarium for participation in advisory board from Merz and AbbVie and has received compensation for speaker-related activities from AbbVie, UCB, Lundbeck, Bial, Neuroderm, Zambon, Allergan, Ipsen. Roberta Zangaglia has received honoraria for speaker-related activities from AbbVie and Boston Scientific. Giuseppe Meco has nothing to disclose. Giuliana Gualberti and Gabriella Melzi are employees of AbbVie Italy and may own AbbVie stocks/options.
: The protocol of the study was approved by the Ethics Committee of each local health authority and each patient provided informed consent. The study was conducted in accordance with the principles of the International Conference on Harmonization Good Clinical Practices.